DeutschNewstral
Article
Ars Technica on 2021-06-09 01:26
A “disgraceful decision:” Researchers blast FDA for approving Alzheimer’s drug
Related news
First new Alzheimer’s drug in decades receives controversial FDA approvalnewatlas.com
FDA approves Biogen’s controversial Alzheimer’s drugNew York Post
FDA conditionally approves controversial Alzheimer’s drugThe Hindu- BFDA approval of new Alzheimer’s drug Aduhelm, developed in part by Brown researchers, mired in controversybrowndailyherald.com
- AAdvocates blast CMS for denying access to FDA-approved Alzheimer’s treatmentaugustafreepress.com
FDA approves much-debated Alzheimer’s drug panned by expertsThe Day
FDA Approves 'First-of-Its-Kind' Alzheimer’s Treatmentbreitbart.com- FDA calls for federal investigation into approval of Alzheimer’s drugNew York Post
- TFDA Approves Alzheimer’s Medicationtoday.uconn.edu
FDA head calls for inquiry into Alzheimer’s drug reviewSeattle Times- FDA approved controversial Alzheimer’s drug despite objections from staffNew York Post
- FFDA approves Biogen Alzheimer’s drugft.com
- FDA Alzheimer’s call slammed as “Worst drug approval in recent US history”newatlas.com
- The resurrection of a failed Alzheimer’s drug set to test FDA approvalnewatlas.com
FDA Approves Controversial Alzheimer’s Drug, the First of Its Kind in 20 Yearsobserver.com- Three experts resign as FDA advisors over approval of Alzheimer’s drugArs Technica
- MBiogen’s FDA-approved Alzheimer’s drug, first new remedy in almost twenty yearsmvtelegraph.com